A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is based in Helsinki, Finland.
Financial Summary
| Share Statistics | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $135.4 | $1,904.5 | 25% |
|
| Shares Out (Mil) | 68.3 | 79.2 | 54% |
|
| Institutional Ownership | 7.2% | 86.0% | 6% |
|
| Float (Mil) | 29.9 | 58.8 | 36% |
|
| Beta | 0.23 | 0.75 | 14% |
|
| Avg Daily Volume (000s) | 184 | 722 | 44% |
|
| Price Change (52-week) |
na | 82.2% | na |
|
| Growth | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 18.5% | 10.3% | 79% |
|
| Net Income (5yr) | (12.9%) | (0.7%) | 27% |
|
| EPS (5yr) | (4.8%) | 2.1% | 25 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.2%) | (17.4%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6 | $1,505 | 7% |
|
| Net Income (TTM) (Mil) | ($21) | $32 | 23% |
|
| EPS (TTM) | ($0.350) | $0.300 | 29% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | $160 | 18% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $2 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $421 | 22% |
|
| Enterprise Value (Q1) (Mil) | $46 | $2,459 | 16% |
|
| Valuation | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.84 | na |
|
| P/E | na | 27.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | NHLTY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 51.7% | 27.9% | 64% |
|
| Net Margin | (335.7%) | 1.4% | 3% |
|
| ROA | (27.4%) | 2.2% | 17% |
|
| ROE | (31.6%) | 6.9% | 19% |
|
| Liabilities to Assets | 16.1% | 61.2% | 10% |
|
| F-Score | na | 5 | na |
|
Nightingale Health Oyj did not pass any screens on 11/6/2026.
